Loading...
Back to narrative

AnalystConsensusTarget updated the narrative for CRISIL

Analysts Lift CRISIL Price Target as Revenue Growth and Margins Drive Upbeat Outlook

CRISIL logo
CRISIL
AnalystConsensusTarget
Not Invested
Published 13 Jul 2025

Update shared on 21 Oct 2025

Fair value Increased 2.65%
PreviousNext
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-22.7%
7D
1.1%

CRISIL Price Target Raised to ₹5,056.5 as Analysts Note Improved Growth and Margins

Analysts have increased their price target for CRISIL from ₹4,926 to ₹5,056.5. They cite strengthened revenue growth and higher profit margins, which offset a slight uptick in discount rate estimates.

What's in the News

  • The Board of Directors has approved the payment of a third interim dividend of INR 16 per equity share of face value INR 1 each for the financial year ending December 31, 2025. The payment is scheduled for November 6, 2025.
  • A Board Meeting was held on October 17, 2025 to consider and approve the unaudited consolidated and standalone financial results for the third quarter and nine months period ended September 30, 2025, and to discuss the payment of the third interim dividend.
  • A Special/Extraordinary Shareholders Meeting is scheduled for October 25, 2025 via postal ballot in India.

Valuation Changes

  • Consensus Analyst Price Target has risen from ₹4,926 to ₹5,056.5.
  • Discount Rate has increased slightly from 14.77% to 14.79%.
  • Revenue Growth projection has increased from 11.25% to 13.02%.
  • Net Profit Margin expectation has improved from 23.61% to 24.39%.
  • Future P/E multiple estimate has decreased from 49.48x to 45.57x.

Have other thoughts on CRISIL?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.